Skip to main content

Advertisement

SpringerLink
Log in

Mortality in patients with systemic lupus erythematosus in Colombia: a case series

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

A Correction to this article was published on 21 May 2019

This article has been updated

Abstract

Introduction

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease associated with high mortality rates. This study aimed to describe the main causes of death in a case series of SLE patients attended in a single center in Colombia.

Methods

We conducted a retrospective review and analysis of records of SLE patients who died between January 2011 and June 2017. We extracted the main causes of death and described variables associated with this outcome as well as variables associated with the disease and its treatment.

Results

From a total of 1776 patients with SLE, we identified 49 fatal cases (89.8% women, n = 44). The average age at death was 40.6 years (SD 17.4), and patients had a median of 4.5 years (IQR 2–8) of disease duration. The main findings included lymphopenia in 44 patients (89.9%), biopsy-confirmed lupus nephritis (LN)—types IV and VI—in 38 (77.6%), catastrophic antiphospholipid syndrome (CAPS) in 8 (16.3%), and persistent hypocomplementemia (C3 and C4) in 8 (16.3%). The median SLE disease activity index (SLEDAI-2K) score at the time of death was 19 (IQR 11–39). The main cause of death was SLE activity and lupus-induced damage in 22 (44.9%) patients.

Conclusion

The main causes of death included SLE activity refractory to immunosuppressive treatment, and nosocomial bacterial infections. The patients who died had persistently high SLEDAI scores, types IV and VI LN, associated antiphospholipid syndrome, and persistent hypocomplementemia, requiring severe immunosuppression and prolonged hospitalization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Change history

  • 21 May 2019

    The presentation of data on the Table 3 of the published version of the above mentioned article was incorrect. The heading “<Emphasis Type="Bold">Bacterial infections</Emphasis>” should be presented under the heading “<Emphasis Type="Bold">Infections</Emphasis>”. The original article has been corrected.

References

  1. Bernatsky S, Boivin J-F, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, el-Gabalawy H, McCarthy T, St. Pierre Y, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557. https://doi.org/10.1002/art.21955

    Article  CAS  PubMed  Google Scholar 

  2. Kasitanon N, Magder LS, Petri M (2006) Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore) 85:147–156. https://doi.org/10.1097/01.md.0000224709.70133.f7

    Article  Google Scholar 

  3. Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 18(21):21. https://doi.org/10.1007/s11926-016-0571-2

    Article  PubMed  Google Scholar 

  4. Pons-Estel GJ, Ugarte-Gil MF, Alarcón GS (2017) Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol 13:799–814. https://doi.org/10.1080/1744666X.2017.1327352

    Article  CAS  PubMed  Google Scholar 

  5. Danila MI, Pons-Estel GJ, Zhang J, Vila LM, Reveille JD, Alarcon GS (2008) Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology 48:542–545. https://doi.org/10.1093/rheumatology/kep012

    Article  Google Scholar 

  6. Andrade RM, Alarcón GS, Fernández M, Apte M, Vilá LM, Reveille JD, LUMINA Study Group (2007) Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. Arthritis Rheum 56:622–630. https://doi.org/10.1002/art.22375

    Article  PubMed  Google Scholar 

  7. Lee YH, Choi SJ, Ji JD, Song GG (2016) Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis. Lupus 25:727–734. https://doi.org/10.1177/0961203315627202

    Article  CAS  PubMed  Google Scholar 

  8. Pons-Estel GJ, Catoggio LJ, Cardiel MH, Bonfa E, Caeiro F, Sato E, Massardo L, Molina-Restrepo JF, Toledano MG, Barile-Fabris LA, Amigo MC, Acevedo-Vásquez EM, Abadi I, Wojdyla D, Alarcón-Riquelme ME, Alarcón GS, Pons-Estel BA (2015) Lupus in Latin-American patients: lessons from the GLADEL cohort. Lupus 24:536–545. https://doi.org/10.1177/0961203314567753

    Article  CAS  PubMed  Google Scholar 

  9. Legge A, Kirkland S, Rockwood K, Andreou P, Bae SC, Gordon C, Romero-Diaz J, Sanchez-Guerrero J, Wallace DJ, Bernatsky S, Clarke AE, Merrill JT, Ginzler EM, Fortin P, Gladman DD, Urowitz MB, Bruce IN, Isenberg DA, Rahman A, Alarcón GS, Petri M, Khamashta MA, Dooley MA, Ramsey-Goldman R, Manzi S, Steinsson K, Zoma AA, Aranow C, Mackay M, Ruiz-Irastorza G, Lim SS, Inanc M, van Vollenhoven RF, Jonsen A, Nived O, Ramos-Casals M, Kamen DL, Kalunian KC, Jacobsen S, Peschken CA, Askanase A, Hanly JG (2019) Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus. Arthritis Rheum:0–3. https://doi.org/10.1002/art.40859

    Article  Google Scholar 

  10. Rees F, Doherty M, Grainge MJ, Lanyon P, Davenport G, Zhang W (2016) Mortality in systemic lupus erythematosus in the United Kingdom 1999–2012. Rheumatology 55:854–860. https://doi.org/10.1093/rheumatology/kev424

    Article  PubMed  Google Scholar 

  11. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725. https://doi.org/10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y

    Article  CAS  PubMed  Google Scholar 

  12. Merola J, Bermas B, Lu B, Karlson EW, Massarotti E, Schur PH, Costenbader KH (2014) Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus 23:778–784. https://doi.org/10.1177/0961203314526291

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Costi LR, Iwamoto HM, Neves DC de O, Caldas CAM (2017) Mortality from systemic erythematosus lupus in Brazil: evaluation of causes according to the government health database. Rev Bras Reumatol Engl Ed 57:574–582. https://doi.org/10.1016/J.RBRE.2017.09.001

    Article  PubMed  Google Scholar 

  14. Bruce IN, O’Keeffe AG, Farewell V et al (2015) Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort. Ann Rheum Dis 74:1706–1713. https://doi.org/10.1136/annrheumdis-2013-205171

    Article  CAS  PubMed  Google Scholar 

  15. Gómez-Puerta JA, Barbhaiya M, Guan H, Feldman CH, Alarcón GS, Costenbader KH (2015) Racial/ethnic variation in all-cause mortality among United States Medicaid recipients with systemic lupus erythematosus: a Hispanic and Asian paradox. Arthritis Rheum 67:752–760. https://doi.org/10.1002/art.38981

    Article  Google Scholar 

  16. Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825–835. https://doi.org/10.2215/CJN.05780616

    Article  PubMed  Google Scholar 

  17. Feldman CH, Hiraki LT, Winkelmayer WC, Marty FM, Franklin JM, Kim SC, Costenbader KH (2015) Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis. Arthritis Rheum 67:1577–1585. https://doi.org/10.1002/art.39070

    Article  Google Scholar 

  18. Ichinose K, Kitamura M, Sato S, Fujikawa K, Horai Y, Matsuoka N, Tsuboi M, Nonaka F, Shimizu T, Fukui S, Umeda M, Koga T, Kawashiri S, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Nishino T, Kawakami A (2019) Factors predictive of long-term mortality in lupus nephritis: a multicenter retrospective study of a Japanese cohort. Lupus 28:295–303. https://doi.org/10.1177/0961203319826690

    Article  CAS  PubMed  Google Scholar 

  19. Agarwal S, Elliott JR, Manzi S (2009) Atherosclerosis risk factors in systemic lupus erythematosus. Curr Rheumatol Rep 11:241–247

    Article  PubMed  Google Scholar 

  20. Turesson C, O’Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722–727. https://doi.org/10.1136/ARD.62.8.722

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Rodríguez-Pintó I, Moitinho M, Santacreu I, Shoenfeld Y, Erkan D, Espinosa G, Cervera R, CAPS Registry Project Group (European Forum on Antiphospholipid Antibodies) (2016) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry. Autoimmun Rev 15:1120–1124. https://doi.org/10.1016/J.AUTREV.2016.09.010

    Article  PubMed  Google Scholar 

  22. Ocampo-Piraquive V, Nieto-Aristizábal I, Cañas CA, Tobón GJ (2018) Mortality in systemic lupus erythematosus: causes, predictors and interventions. Expert Rev Clin Immunol 14:1043–1053. https://doi.org/10.1080/1744666X.2018.1538789

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. GIRAT: Grupo de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Fundación Valle del Lili and Universidad Icesi, Cali, Colombia

    David Aguirre-Valencia, Iván Posso-Osorio, Juan Naranjo-Escobar, Ivana Nieto-Aristizábal, Gabriel J. Tobón & Carlos A. Cañas

  2. Medical School, Universidad Icesi, Cali, Colombia

    David Aguirre-Valencia, Ana Suárez-Avellaneda, Vanessa Ocampo-Piraquive, Gabriel J. Tobón & Carlos A. Cañas

  3. Immunology Laboratory, Fundación Valle del Lili, Cra 98 No. 18-49, Cali, Colombia

    Gabriel J. Tobón

Authors
  1. David Aguirre-Valencia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ana Suárez-Avellaneda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vanessa Ocampo-Piraquive
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Iván Posso-Osorio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Juan Naranjo-Escobar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ivana Nieto-Aristizábal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gabriel J. Tobón
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carlos A. Cañas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriel J. Tobón.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original version of this article was revised: The Table 3 heading “Bacterial infections” should be presented under the heading “Infections”. The original article has been corrected.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aguirre-Valencia, D., Suárez-Avellaneda, A., Ocampo-Piraquive, V. et al. Mortality in patients with systemic lupus erythematosus in Colombia: a case series. Clin Rheumatol 38, 1865–1871 (2019). https://doi.org/10.1007/s10067-019-04546-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04546-w

Keywords

Search

Navigation